(Q51340875)

English

Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years.

scientific article published on 10 May 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

cholangiocarcinoma

0 references

1 reference

based on heuristic

inferred from title

author name string

Marc Pracht

1

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

Guillaume Le Roux

2

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

Laurent Sulpice

3

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

Habiba Mesbah

4

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

Sylvain Manfredi

5

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

Odile Audrain

6

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

Karim Boudjema

7

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

Jean-Luc Raoul

8

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

Eveline Boucher

9

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

publication date

10 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

58

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

2

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

134-141

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Biliary tract cancers.

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Cholangiocarcinoma: update and future perspectives.

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Cholangiocarcinoma: a compact review of the literature

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Cholangiocarcinoma: Current concepts and insights

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Mechanisms of biliary carcinogenesis and growth

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

The role of chemotherapy in biliary tract carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma.

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Gallbladder cancer: current status

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Phase II study of erlotinib in patients with advanced biliary cancer

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Prospective phase II trial of gemcitabine in combination with irinotecan as first-line chemotherapy in patients with advanced biliary tract cancer

1 reference

https://api.crossref.org/works/10.1159%2F000337289

21 January 2018

Identifiers

10.1159/000337289

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22572213

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51340875&oldid=1234933052"